Report cover image

Red Biotechnology Market: Current Analysis and Forecast (2022-2028)

Publisher UnivDatos Market Insights
Published Jan 11, 2022
Length 140 Pages
SKU # Univ17631646

Description

Red Biotechnology Market: Current Analysis and Forecast (2022-2028)

Red biotechnology is the branch of modern biotechnology which is utilized in the field of medicine. It is a process that utilizes organisms to improve health care and help the body to fight diseases. The significant rise in the advancement of stem cell research fields to manufacturing new and personalized methods is attributed to the market growth of the red biotechnology market. Furthermore, the increasing demand for better and patient-specific treatments also attributes to the significant market share of red biotechnology.

The rising investment in research is expected to drive the global red biotechnology market at a CAGR of 6%, during the forecast period. Other factors such as rise in the incidences of chronic diseases, the rapid growth of the biopharmaceutical company, and increase in healthcare expenditure are also affecting the market’s growth positively.

COVID-19 has a staggering effect and a negative impact on the global economy due to imposed lockdowns and government restrictions. However, the market for red biotechnology faced an upsurge during the pandemic due to the increasing government efforts to develop a treatment for the COVID-19 pandemic.
  • Based on the application, the market has been categorized into biopharmaceutical production, gene therapy, pharmacogenomics, genetic testing, and others. Among them, the pharmacogenomics segment is expected to have significant growth in the market. Pharmacogenomics is the study of the genes that affect the response of the immune system to drugs. Furthermore, the rising prevalence of various diseases and increased usage of pharmacogenomics in them attributes to the market growth of red biotechnology.
  • Based on the product type, the market has been categorized into gene recombinant drugs, human vaccines, blood products, diagnostics reagents, personalized medicines, and others. Among them, the human vaccines segment is expected to have significant growth in the market during the forecast period. The increasing demand for vaccines for the complete eradication of disease and increasing efforts of research organizations on the development of vaccines is attributed to segmental growth.
  • For a better understanding of the market adoption of the red biotechnology industry, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a significant red biotechnology market due to the presence of better research infrastructure, higher prevalence of chronic diseases, and higher R&D infrastructure. According to 2022 facts and figures from the American Cancer Society over 1.9 million new cancer cases are expected to be diagnosed in the United States in 2022 and this estimate excludes basal cell and squamous cell skin cancers, which are not required to be reported to cancer registries, and carcinoma in situ (non-invasive cancer) except for urinary bladder. The 5-year relative survival rate for all cancers combined has increased substantially from 39% to 68% among white people and from 27% to 63% among black people. This greatly highlights the use of red biotechnology in developing new and effective treatments for the population, in turn boosting the demand for biotechnological products.
  • Some of the major players operating in the market are Pfizer Inc., AstraZeneca PLC, F. Hoffmann-La Roche Ltd, Celgene Corporation, Takeda Pharmaceutical Company Limited, Biogen Inc., Amgen Inc., Gilead Sciences Inc., Merck & Co. Inc., and CSL Limited.

Table of Contents

140 Pages
1 MARKET INTRODUCTION
1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation
2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1. Research Process of the Red Biotechnology Market
2.2. Research Methodology of the Red Biotechnology Market
2.3. Respondent Profile
3 MARKET SYNOPSIS
4 EXECUTIVE SUMMARY
5 IMPACT OF COVID-19 ON THE RED BIOTECHNOLOGY MARKET
6 RED BIOTECHNOLOGY MARKET REVENUE (USD BN), 2020-2028F
7 MARKET INSIGHTS BY APPLICATION
7.1. Biopharmaceutical Production
7.2. Gene therapy
7.3. Pharmacogenomics
7.4. Genetic Testing
7.5. Others
8 MARKET INSIGHTS BY PRODUCT TYPE
8.1. Gene Recombinant Drugs
8.2. Human Vaccines
8.3. Blood Products
8.4. Diagnostics Reagents
8.5. Personalized Medicines
8.6. Others
9 MARKET INSIGHTS BY REGION
9.1. North America
9.1.1. U.S.
9.1.2. Canada
9.1.3. Rest of North America
9.2. Europe
9.2.1. Germany
9.2.2. U.K.
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. Rest of Asia-Pacific
9.4. Rest of World
10 RED BIOTECHNOLOGY MARKET DYNAMICS
10.1. Market Drivers
10.2. Market Challenges
10.3. Impact Analysis
11 RED BIOTECHNOLOGY MARKET OPPORTUNITIES
12 RED BIOTECHNOLOGY MARKET TRENDS
13 DEMAND AND SUPPLY-SIDE ANALYSIS
13.1. Demand Side Analysis
13.2. Supply Side Analysis
14 VALUE CHAIN ANALYSIS
15 COMPETITIVE SCENARIO
15.1. Competitive Landscape
15.1.1. Porters Fiver Forces Analysis
16 COMPANY PROFILED
16.1. Pfizer Inc.
16.2. AstraZeneca PLC
16.3. F. Hoffmann-La Roche Ltd
16.4. Celgene Corporation
16.5. Takeda Pharmaceutical Company Limited
16.6. Biogen Inc.
16.7. Amgen Inc.
16.8. Gilead Sciences Inc.
16.9. Merck & Co. Inc.
16.10. CSL Limited
17 DISCLAIMER

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us